Literature DB >> 1889923

Prediction of resumption of drinking in posttreatment alcoholics.

S W Glenn1, O A Parsons.   

Abstract

The ability of five factors (depressive symptomatology, neuropsychological performance, psychosocial maladjustment, previous treatment history, and childhood attention deficit disorder symptomatology) to predict relapse was examined in a follow-up experimental design. Fifty-eight male and 45 female alcoholics were interviewed immediately following release from inpatient treatment units. Fourteen months later, 41 subjects (41%) were classified as resumers; 62 (59%) were abstainers. Resumers showed significantly poorer scores than abstainers on all five of the predictor variables. Discriminant function analysis resulted in 75% correct classification of resumers and abstainers (chi 2 = 22.1, p less than .001). Stepwise multiple regression resulted in isolation of depressive symptomatology as the best single predictor of relapse.

Entities:  

Mesh:

Year:  1991        PMID: 1889923     DOI: 10.3109/10826089109053186

Source DB:  PubMed          Journal:  Int J Addict        ISSN: 0020-773X


  20 in total

1.  Dopamine receptor imaging in alcohol dependency: should personality traits be taken into account?

Authors:  I Goethals; C Van De Wiele; K Audenaert
Journal:  Eur J Nucl Med       Date:  2001-11

2.  Cortical thickness, surface area, and volume of the brain reward system in alcohol dependence: relationships to relapse and extended abstinence.

Authors:  Timothy C Durazzo; Duygu Tosun; Shannon Buckley; Stefan Gazdzinski; Anderson Mon; Susanna L Fryer; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2011-03-15       Impact factor: 3.455

3.  Brain morphology at entry into treatment for alcohol dependence is related to relapse propensity.

Authors:  Valerie A Cardenas; Timothy C Durazzo; Stefan Gazdzinski; Anderson Mon; Colin Studholme; Dieter J Meyerhoff
Journal:  Biol Psychiatry       Date:  2011-05-20       Impact factor: 13.382

4.  Cortical perfusion in alcohol-dependent individuals during short-term abstinence: relationships to resumption of hazardous drinking after treatment.

Authors:  Timothy C Durazzo; Stefan Gazdzinski; Anderson Mon; Dieter J Meyerhoff
Journal:  Alcohol       Date:  2010-05       Impact factor: 2.405

5.  Quality of life, alcohol detoxification and relapse: is quality of life a predictor of relapse or only a secondary outcome measure?

Authors:  Rocco Luigi Picci; Francesco Oliva; Marco Zuffranieri; Paola Vizzuso; Luca Ostacoli; Alessandro Jaretti Sodano; Pier Maria Furlan
Journal:  Qual Life Res       Date:  2014-06-15       Impact factor: 4.147

6.  A retrospective study of gender differences in depressive symptoms and risk of relapse in patients with alcohol dependence.

Authors:  Osama A Abulseoud; Victor M Karpyak; Terry Schneekloth; Daniel K Hall-Flavin; Larissa L Loukianova; Jennifer R Geske; Joanna M Biernacka; David A Mrazek; Mark A Frye
Journal:  Am J Addict       Date:  2013-05-30

7.  Combined neuroimaging, neurocognitive and psychiatric factors to predict alcohol consumption following treatment for alcohol dependence.

Authors:  Timothy C Durazzo; Stefan Gazdzinski; Ping-Hong Yeh; Dieter J Meyerhoff
Journal:  Alcohol Alcohol       Date:  2008-09-24       Impact factor: 2.826

8.  Outpatient alcoholism treatment--24-month outcome and predictors of outcome.

Authors:  Michael Soyka; Peggy Schmidt
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-29

9.  Deficit in brain reward function and acute and protracted anxiety-like behavior after discontinuation of a chronic alcohol liquid diet in rats.

Authors:  Daria Rylkova; Hina P Shah; Elysia Small; Adrie W Bruijnzeel
Journal:  Psychopharmacology (Berl)       Date:  2008-12-02       Impact factor: 4.530

10.  Gender differences in interpersonal problems of alcohol-dependent patients and healthy controls.

Authors:  Sandra E Mueller; Bigna Degen; Sylvie Petitjean; Gerhard A Wiesbeck; Marc Walter
Journal:  Int J Environ Res Public Health       Date:  2009-12-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.